Walleye Trading’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.3K | Buy |
+640
| New | +$23.3K | ﹤0.01% | 844 |
|
|
2024
Q1 | – | Sell |
-9,113
| Closed | -$436K | – | 2173 |
|
|
2023
Q4 | $436K | Sell |
9,113
-5,535
| -38% | -$265K | ﹤0.01% | 866 |
|
|
2023
Q3 | $522K | Buy |
14,648
+14,348
| +4,783% | +$512K | ﹤0.01% | 721 |
|
|
2023
Q2 | $13.8K | Buy |
+300
| New | +$13.8K | ﹤0.01% | 1079 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2264 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2344 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2473 |
|
|
2022
Q2 | – | Sell |
-21,105
| Closed | -$1.53M | – | 2485 |
|
|
2022
Q1 | $1.53M | Buy |
21,105
+16,982
| +412% | +$1.23M | ﹤0.01% | 345 |
|
|
2021
Q4 | $347K | Buy |
+4,123
| New | +$347K | ﹤0.01% | 975 |
|
|
2021
Q2 | – | Sell |
-1,033
| Closed | -$118K | – | 2248 |
|
|
2021
Q1 | $118K | Sell |
1,033
-13,816
| -93% | -$1.58M | ﹤0.01% | 1217 |
|
|
2020
Q4 | $2.06M | Buy |
+14,849
| New | +$2.06M | 0.01% | 250 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1739 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1676 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1642 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1663 |
|
|
2016
Q1 | – | Sell |
-216
| Closed | -$24K | – | 2362 |
|
|
2015
Q4 | $24K | Buy |
216
+116
| +116% | +$12.9K | ﹤0.01% | 1438 |
|
|
2015
Q3 | $10K | Buy |
+100
| New | +$10K | ﹤0.01% | 1428 |
|